. This has led to speculation on whether serum GH BP measurement may be useful as a simple indicator of hepatic GH receptor status (16) . Limited evidence in the rodent suggests a relationship between GH BP levels and hepatic somatogenic binding (17, 18 recently suggested (19 Hepatic growth hormone receptors (Table 2) The specific binding of [12,I] (Fig. 3, Table 3 ). An age effect was seen in the ratio of serum GH BP to hepatic ['^IJbGH binding, this ratio being higher in the infant animals (p = 0.03), but no effect of pGH treatment on this ratio was evident.
Serum GH BP correlated significantly with serum IGF-I both in the overall study group (Fig. 3, Table 3 ). Serum IGF-I also correlated signifi¬ cantly with membrane capacity (r (Fig. 3 , Table 3 ).
Discussion
The relationship of the serum GH BP to the hepatic membrane bound GH receptor is of considerable interest.
The structural identity of the serum-binding protein to the extracellular hormone-binding domain of the mem¬ brane bound receptor (15) has led to investigation and speculation on possible mechanisms for its production. Proteolytic cleavage of the GH receptor near the transmembrane domain and release of the extramembranous portion into the circulation is one possible mechanism (12) . Separate synthesis and secretion of the BP has also been suggested and could be explained by alternative mRNA splicing mechanisms for the BP and receptor. In the pregnant mouse (32) and the rat (33) Specific binding (%) (37) and that the high affinity GH BP competes for GH binding with a similar affinity to the membrane bound receptor (13 
